Table 2.
Comparison of selected clinical data between patients with fatty liver and no/mild and advanced fibrosis
| Fibrosis 0-2 (n = 48) | Fibrosis 3-4 (n = 14) | P value | |
| Age (yr) | 45 ± 12 | 51 ± 11 | 0.096 |
| BMI (19-25 kg/m2) | 28.68 ± 3.85 | 30.64 ± 5.05 | 0.135 |
| AST (< 38 IU/L) | 51.27 ± 38.75 | 80.69 ± 55.27 | 0.091 |
| ALT (< 41 IU/L) | 89.10 ± 53.64 | 75.85 ± 71.39 | 0.462 |
| AST/ALT ratio | 0.65 ± 0.31 | 1.33 ± 0.55 | 0.001 |
| PLT (150-400 × 109/L) | 231.08 ± 66.51 | 201.54 ± 68.57 | 0.161 |
| Glucose (3.89-5.83 mmol/L) | 5.36 ± 0.74 | 7.08 ± 20.5 | 0.020 |
| HOMA (> 1.8) | 6.0 ± 8.4 | 13.1 ± 10.7 | 0.144 |
| Fe (10.56-228.28 μmol/L) | 19.9 ± 7.32 | 26.9 ± 15.0 | 0.028 |
| Ferritin (629.2-7999.3 pmol/L) | 742.2 ± 753.9 | 1934.4 ± 3914.3 | 0.362 |
| Albumin (34-48 g/L) | 4.64 ± 0.38 | 4.31 ± 0.37 | 0.017 |
| HBA1c (4.8%-5.9%) | 5.92 ± 0.96 | 7.48 ± 1.78 | 0.121 |
| Transferrin saturation (< 45%) | 38.68 ± 30.88 | 49.06 ± 28.64 | 0.361 |